Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making
van Munster, C.E.P., Kaya, L., Lam, K.H., Kalkers, N.F., Killestein, J., Uitdehaag, B.M.J.Volume:
38
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2019.101489
Date:
February, 2020
File:
PDF, 465 KB
english, 2020